Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln

[ad_1] Roche aims to buy Carmot Therapeutics, a California-based pharmaceutical firm developing drugs to treat obesity and diabetes. The Swiss pharmaceutical company said it has entered an agreement to acquire…

Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France

[ad_1] Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it seeks to meet rising demand for…

Opinion | The Covid Vaccine Windfall Turns for Pfizer and Moderna

[ad_1] Updated Nov. 19, 2023 3:03 pm ET The U.S. was in a fit of Covid panic during Thanksgiving week two years ago. The Omicron variant had emerged like a…

Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity

[ad_1] Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest more than $6 billion to boost production capacity. Copyright ©2023 Dow Jones…

Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say

[ad_1] A unit of Chinese contract drugmaker Wuxi Biologics closed its order book a day early for its initial public offering and is likely to price the deal at the…

Opinion | Is AI a Painkiller or a Vitamin?

[ad_1] Some companies will use it to reduce expenses, others to create new markets. [ad_2] Source link

Obesity Drug Demand Outstrips Supply

[ad_1] Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as an obesity treatment before the end of the year, which would lead to…

GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings

[ad_1] Updated Nov. 1, 2023 4:08 am ET GSK PLC raised its guidance after third-quarter net profit rose mainly due to the U.S. launch of its Arexvy vaccine, although it…

‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

[ad_1] Merck and Pfizer are the latest big pharma companies to invest in this booming area. [ad_2] Source link

Novartis Raises Earnings Guidance After Key Drugs Boost Profit, Sales

[ad_1] Updated Oct. 24, 2023 3:04 am ET Novartis raised its full-year earnings guidance for the third time this year after it reported higher net profit and sales for the…